122 related articles for article (PubMed ID: 4007403)
1. A case of chronic liver disease due to tolazamide.
Nakao NL; Gelb AM; Stenger RJ; Siegel JH
Gastroenterology; 1985 Jul; 89(1):192-5. PubMed ID: 4007403
[TBL] [Abstract][Full Text] [Related]
2. Lichenoid drug reactions to chlorpropamide and tolazamide.
Barnett JH; Barnett SM
Cutis; 1984 Dec; 34(6):542-4. PubMed ID: 6240374
[TBL] [Abstract][Full Text] [Related]
3. Tolazamide-induced cholestasis.
Bridges ME; Pittman FE
South Med J; 1980 Aug; 73(8):1072-4. PubMed ID: 7403921
[TBL] [Abstract][Full Text] [Related]
4. Tolazamide hepatotoxicity. A case report.
Van Thiel DH; De Belle R; Mellow M; Widerlite L; Philipps E
Gastroenterology; 1974 Sep; 67(3):506-10. PubMed ID: 4855219
[No Abstract] [Full Text] [Related]
5. Comparision of chlorpropamide with tolazamide in the treatment of diabetes mellitus.
Sherwood G; Bressler R
Curr Ther Res Clin Exp; 1968 Aug; 10(8):399-405. PubMed ID: 4970053
[No Abstract] [Full Text] [Related]
6. Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.
Schmeltz R; Wendorff HJ; Field JB
J Clin Endocrinol Metab; 1978 Apr; 46(4):519-27. PubMed ID: 755038
[No Abstract] [Full Text] [Related]
7. Tolazamide-induced hepatic dysfunction.
LoIudice TA; Lang JA
Am J Gastroenterol; 1978 Jan; 69(1):81-3. PubMed ID: 645691
[TBL] [Abstract][Full Text] [Related]
8. [ON TOLAZAMIDE: APROPOS OF A NEW HYPOGLYCEMIC SULFANYLUREA AND OF ACQUIRED SULFANYLUREAU RESISTANCE].
KLINGER R; DALLECOSTE P
Minerva Med; 1964 Jul; 55():2237-40. PubMed ID: 14179829
[No Abstract] [Full Text] [Related]
9. Potentiation of hypoglycemic effect of chlorpropamide and phenfromin by halofenate.
Kudzma DJ; Friedberg SJ
Diabetes; 1977 Apr; 26(4):291-5. PubMed ID: 321288
[TBL] [Abstract][Full Text] [Related]
10. Status of problem of usage of tolbutamide. Preliminary statements.
Diabetes; 1970 Jun; 19(6):467-8. PubMed ID: 5467867
[No Abstract] [Full Text] [Related]
11. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
Prendergast BD
Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
[TBL] [Abstract][Full Text] [Related]
12. Long-term results with oral hypoglycemic drugs.
Moss JM; DeLawter DE
J Am Geriatr Soc; 1973 Feb; 21(2):72-6. PubMed ID: 4688111
[No Abstract] [Full Text] [Related]
13. CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
GRINNELL EH; SKILLMAN TG; BARSE R; MOLLER CL
Curr Ther Res Clin Exp; 1964 Jul; 6():433-41. PubMed ID: 14203273
[No Abstract] [Full Text] [Related]
14. Clinical pharmacology of oral antidiabetic agents (first of two parts).
Shen SW; Bressler R
N Engl J Med; 1977 Mar; 296(9):493-7. PubMed ID: 319363
[No Abstract] [Full Text] [Related]
15. Diabetes mellitus: the thin maturity-onset diabetic.
Br Med J; 1972 Sep; 3(5828):692-4. PubMed ID: 4631184
[No Abstract] [Full Text] [Related]
16. Oral sulphonylureas in the management of diabetes.
Jackson WP
S Afr Med J; 1971 Jan; 45(5):118-23. PubMed ID: 4925995
[No Abstract] [Full Text] [Related]
17. Insulin-independent diabetes mellitus.
Bricker LA; Mintz DH
Med Clin North Am; 1971 Mar; 55(2):295-304. PubMed ID: 4926053
[No Abstract] [Full Text] [Related]
18. [Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].
Vogel G; Krummel E
Arzneimittelforschung; 1969 Jul; 19(7):1128-30. PubMed ID: 5394514
[No Abstract] [Full Text] [Related]
19. [Results of oral therapy of diabetes mellitus with the new sulfonylurea tolazamide under ambulatory conditions].
Düntsch G
Arzneimittelforschung; 1970 Apr; 20(4):577-9. PubMed ID: 5467825
[No Abstract] [Full Text] [Related]
20. [Results of oral therapy of diabetes mellitus with the new sulfonylurea tolazamide under ambulatory conditions].
Düntsch G
Arzneimittelforschung; 1970 Apr; 20(4):575-9. PubMed ID: 5467824
[No Abstract] [Full Text] [Related]
[Next] [New Search]
